The Association between serotonin 2C receptor polymorphisms and weight gain and eating behavior in patients using mirtazapine a prospective follow-up study

Journal of Clinical Psychopharmacology

Volumn 30, Issue 2, 2010, Pages 207-209

  Risselada, Arne J ^a   Mulder, Hans ^a   Heerdink, Eibert R ^a   Grube, Anne Marie ^b   Wilmink, Frederik W ^b   Egberts, Toine C G ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Wilhelmina Ziekenhuis   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MIRTAZAPINE; SEROTONIN 2C RECEPTOR;

ADULT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEEDING BEHAVIOR; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LETTER; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT GAIN;

ADULT; AGED; FEEDING BEHAVIOR; FEMALE; FOLLOW-UP STUDIES; HAPLOTYPES; HUMANS; MALE; MIANSERIN; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RECEPTOR, SEROTONIN, 5-HT2C; WEIGHT GAIN;

EID: 77952149347     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181d489d7     Document Type: Letter

References (9)

1. Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA. 1999;282: 1523-1529. (Pubitemid 29504045)
2. Muller DJ, Muglia P, Fortune T, et al. Pharmacogenetics of antipsychotic-induced weight gain. Pharmacol Res. 2004;49: 309-329.
3. De Luca V, Mueller DJ, de Bartolomeis A, et al. Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis. Int J Neuropsychopharmacol. 2007;10:697-704. (Pubitemid 47517523)
4. Mulder H, Franke B, van der Beek-van der A, et al. The association between HTR2c polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study. Pharmacogenomics J. 2007;7:318-324. (Pubitemid 47471309)
5. Reynolds GP. Weight gain, antipsychotic drug treatment and pharmacogenomics. Pharmacogenomics. 2002;3:567-570.
6. Anttila SAK, Leinonen EVJ. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev. 2001;7: 249-264. (Pubitemid 34016084)
7. Tecott L, Sun L, Akana S, et al. Eating disorder and epilepsy in mice lacking 5HT2C-serotonin receptors. Nature. 1995;374:542-546.
8. Gallant DM, Bishop MP, Bishop G, et al. U-22,394A: a controlled evaluation in chronic schizophrenic patients. Curr Ther Res Clin Exp. 1967;9:579-581.
9. Dremencov E, Weizmann Y, Kinor N, et al. Modulation of dopamine transmission by 5HT2c and 5HT3 receptors: a role in the antidepressant response. Curr Drug Targets. 2006;7:165-175.